Renaissance Technologies (RenTech)'s VIR Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 761,364 shares of Vir Biotechnology, Inc. (VIR) worth $6.82 M, representing 0.01% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in VIR, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2022, adding 950,094 shares. Largest reduction occurred in Q4 2025, reducing 552,636 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Vir Biotechnology (VIR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vir Biotechnology (VIR) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +146,900 | Add 23.91% | 761,364 | $8.96 |
| Q4 2025 | -552,636 | Reduce 47.35% | 614,464 | $6.03 |
| Q3 2025 | +102,600 | Add 9.64% | 1.17 M | $5.71 |
| Q2 2025 | -55,900 | Reduce 4.99% | 1.06 M | $5.04 |
| Q1 2025 | -117,200 | Reduce 9.47% | 1.12 M | $6.48 |
| Q4 2024 | +55,300 | Add 4.68% | 1.24 M | $7.34 |
| Q3 2024 | -147,400 | Reduce 11.09% | 1.18 M | $7.49 |
| Q2 2024 | -26,400 | Reduce 1.95% | 1.33 M | $8.90 |
| Q1 2024 | +61,500 | Add 4.75% | 1.36 M | $10.13 |
| Q4 2023 | -59,800 | Reduce 4.42% | 1.29 M | $10.06 |
| Q3 2023 | +186,300 | Add 15.95% | 1.35 M | $9.37 |
| Q2 2023 | +7,600 | Add 0.65% | 1.17 M | $0.02 |
| Q1 2023 | +102,100 | Add 9.65% | 1.16 M | $0.02 |
| Q4 2022 | -454,094 | Reduce 30.02% | 1.06 M | $0.03 |
| Q3 2022 | +950,094 | Add 168.94% | 1.51 M | $19.28 |
| Q2 2022 | +468,000 | Add 495.76% | 562,400 | $25.47 |
| Q1 2022 | +36,500 | Add 63.04% | 94,400 | $25.72 |
| Q4 2021 | +57,900 | New Buy | 57,900 | $41.87 |
| Q3 2021 | -80,102 | Sold Out | 0 | $0.00 |
| Q2 2021 | +80,102 | New Buy | 80,102 | $47.28 |
| Q2 2020 | -58,500 | Sold Out | 0 | $0.00 |
| Q1 2020 | +58,500 | New Buy | 58,500 | $34.27 |
Renaissance Technologies (RenTech)'s Vir Biotechnology Investment FAQs
Renaissance Technologies (RenTech) first purchased Vir Biotechnology, Inc. (VIR) in Q1 2020, acquiring 58,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Vir Biotechnology, Inc. (VIR) for 22 quarters since Q1 2020.
Renaissance Technologies (RenTech)'s largest addition to Vir Biotechnology, Inc. (VIR) was in Q3 2022, adding 1,512,494 shares worth $29.16 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 761,364 shares of Vir Biotechnology, Inc. (VIR), valued at approximately $6.82 M.
As of the Q1 2026 filing, Vir Biotechnology, Inc. (VIR) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Vir Biotechnology, Inc. (VIR) was 1,512,494 shares, as reported at the end of Q3 2022.